Product Images Striverdi Respimat

This text contains data related to a clinical trial involving four different doses of Olodaterol (2ug, 5ug, 10ug, and 20ug) administered daily to a total of 326 participants. The data recorded includes the average FEV (forced expiratory volume) before and after the treatment, with the number of participants (n) cited for each dose.*

This appears to be a graph showing the comparison of FEV (Forced Expiratory Volume) between two groups, one receiving a medication called "olodaterol" and the other receiving a placebo, over a period of 8 hours. The values on the Y-axis range from 110 to 160, and the time period on the X-axis runs from 0 to 8 hours after medication dosing. However, the output may not be accurate enough to make a definitive interpretation.*

The text is describing two separate items. The first item is a "safety catch", which is not further described or defined. The second item is a "clear base", again with no further description or definition. No context is given for these items, so it is not possible to determine their purpose or significance.*

Striverdic Respimate is an olodaterol inhalation spray with an NDC of 0597-0192-61. It is designed for oral inhalation only and comes in a package that contains 4 grams of the product with 60 metered inhalations. The product should only be used as per the instructions provided by the manufacturers. A video demonstration on the correct usage of the STRIVERDI RESPIMAT inhaler is available on the manufacturer's website or by scanning the provided code. The product is made in Germany and is distributed by Boehringer Ingelheim Pharmaceuticals, Inc. The cartridge needs to be inserted before use, and the product needs to be discarded three months after insertion. Apart from these instructions, no other useful information is available due to the presence of unclear text resulting from .*